Xenotransplantation in Australia: Development of the regulatory process

被引:6
|
作者
Hawthorne, Wayne J. [1 ,2 ]
Cowan, Peter J. [3 ,4 ]
机构
[1] Westmead Hosp, Westmead Inst Med Res, Ctr Transplant & Renal Res, Sydney, NSW, Australia
[2] Univ Sydney, Western Clin Sch, Dept Surg, Sydney, NSW, Australia
[3] St Vincents Hosp Melbourne, Immunol Res Ctr, Melbourne, Vic, Australia
[4] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
关键词
guidelines; international xenotransplantation association; legislation; regulations; world health organisation; xenotransplantation; ISLET XENOTRANSPLANTATION;
D O I
10.1111/xen.12603
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In this commentary, we present a brief history of the development of a national regulatory framework for xenotransplantation clinical research in Australia, including the reasons behind the imposition of a 5-year moratorium in 2005 and its subsequent lifting. We conclude with a summary of current relevant guidelines and standards.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes - Chapter 1: update on national regulatory frameworks pertinent to clinical islet xenotransplantation
    Cozzi, Emanuele
    Toenjes, Ralf R.
    Gianello, Pierre
    Buehler, Leo H.
    Rayat, Gina R.
    Matsumoto, Shinichi
    Park, Chung-Gyu
    Kwon, Ivo
    Wang, Wei
    O'Connell, Philip
    Jessamine, Stewart
    Elliott, Robert B.
    Kobayashi, Takaaki
    Hering, Bernhard J.
    XENOTRANSPLANTATION, 2016, 23 (01) : 14 - 24
  • [32] Sketching and validating the location-based services (LBS) regulatory framework in Australia
    Abbas, Roba
    Michael, Katina
    Michael, M. G.
    Nicholls, Rob
    COMPUTER LAW & SECURITY REVIEW, 2013, 29 (05) : 576 - 589
  • [33] Eros: An Approach for Ensuring Regulatory Compliance of Process Outcomes
    Yin, Quanjun
    Madhavji, Nazim H.
    Pattani, Mahesh
    2013 6TH INTERNATIONAL WORKSHOP ON REQUIREMENTS ENGINEERING AND LAW (RELAW), 2013, : 21 - 24
  • [34] Clinical Islet Xenotransplantation: Development of Isolation Protocol, Anti-Rejection Strategies, and Clinical Outcomes
    Matsumoto, Shinichi
    Matsumoto, Kyohei
    CELLS, 2024, 13 (10)
  • [35] Regulatory considerations in the development and application of biotechnology in Japan
    Yamanouchi, K
    REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES, 2005, 24 (01): : 109 - 115
  • [36] Regulatory and standards development in medical additive manufacturing
    Khalid Rafi
    Alexander Zhonghong Liu
    Matthew Di Prima
    Paul Bates
    Mohsen Seifi
    MRS Bulletin, 2022, 47 : 98 - 105
  • [37] Regulatory and standards development in medical additive manufacturing
    Rafi, Khalid
    Liu, Alexander Zhonghong
    Di Prima, Matthew
    Bates, Paul
    Seifi, Mohsen
    MRS BULLETIN, 2022, 47 (01) : 98 - 105
  • [38] Regulatory Trends in Drug Development in Asia Pacific
    Fengyun Vicky Han
    Karen Weiss
    Therapeutic Innovation & Regulatory Science, 2019, 53 : 497 - 501
  • [39] The process of guideline development
    Jazieh, Abdul-Rahman
    ANNALS OF THORACIC MEDICINE, 2008, 3 (06) : S60 - S61
  • [40] Regulatory Trends in Drug Development in Asia Pacific
    Han, Fengyun
    Weiss, Karen
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2019, 53 (04) : 497 - 501